Professor Paul Cohen is a gynaecological oncologist and clinician scientist at the Western Australian Gynaecological Cancer Service, King Edward Memorial Hospital, and the Harry Perkins Institute of Medical Research in Perth. His research focuses on biomarkers predicting chemotherapy response in ovarian cancer, gynaecological cancer epidemiology, and survivorship.

He chairs ANZGOG’s Research Advisory Committee and serves on its Board of Directors, is Principal Investigator of two multicentre phase 2 trials, and is Co-Chair of the 2026 IGCS Annual Global Meeting Scientific Program Committee.